Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
- DOI
- 10.1021/jm1016279
- Published
- 2011 Jun 23
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/jm1016279,
title = {Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.},
author = {Perez DI and Palomo V and Pérez C and Gil C and Dans PD and Luque FJ and Conde S and Martínez A},
year = {2011},
journal = {Journal of medicinal chemistry},
doi = {10.1021/jm1016279},
url = {https://doi.org/10.1021/jm1016279}
}RIS
TY - JOUR TI - Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds. AU - Perez DI AU - Palomo V AU - Pérez C AU - Gil C AU - Dans PD AU - Luque FJ AU - Conde S AU - Martínez A PY - 2011 JO - Journal of medicinal chemistry DO - 10.1021/jm1016279 UR - https://doi.org/10.1021/jm1016279 ER -
APA
DI, P., V, P., C, P., C, G., PD, D., FJ, L., S, C., & A, M. (2011). Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.. Journal of medicinal chemistry. https://doi.org/10.1021/jm1016279
Source records
- pubmed · retrieved 2026-11-10T09:13:25.450Z